Back to LCT Homepage Targeting Huntington's Disease, Stroke, Type 1 Diabetes and Haemophilia
Information about LCT Living Cell Technologies
LCT - Living Cell Technologies
News updates: Subscribe
Unsubscribe


June 5, 2008
LCT Expands Diabetes Clinical Trial
June 3, 2008
LCT Lists on International OTCQX
May 21, 2008
LCT interviewed by New Zealand TV program, Close Up
May 12, 2008
LCT presents encapsulation technology at conference
May 8, 2008
LCT features on Channel Ten News
May 8, 2008
LCT prepares to list on international OTCQX
 

Analyst Coverage


Taylor Collison Limited Broker Report
March 3, 2008

Taylor Collison Analyst Report
March Download


Intersuisse Broker Report
October 11, 2007

Preliminary Data - Insulin use by 2 patients reduced by more than 25% Download


Taylor Collison Limited Broker Report
October 11, 2007

Promising Results in Russia, Funding Commitments
and NZ Approval Download


Taylor Collison Limited Broker Report
April 17, 2007

NZ Approval to Commence Phase I/II Type 1 Diabetes
Clinical Trial Download


Taylor Collison Limited Broker Report
Febraury 5, 2007

Taylor Collison Broker Analyst Report Download


Financial Gateway to Asia Research Report
October 20, 2006

Financial Gateway to Asia Research Report Download


Taylor Collison Limited Broker Report
September 14, 2005

Taylor Collison Limited Broker Report Download


Hunting Party Securities Research Report
August 29, 2005

Hunting Party Securities Research Report Download


Taylor Collison Limited Broker Report
August 5, 2005

Taylor Collison broker analyst report Download


Taylor Collison Limited Broker Report
September 16, 2004

Taylor Collison broker analyst report Download





Disclaimer: LCT is followed by the analysts listed above. The list will change periodically as analysts start or terminate coverage of LCT, and due to turnover, promotions and the like at the firms listed above. For this reason, the list may not be complete. Please note that any opinions, estimates or forecasts regarding LCT's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of LCT or its management. LCT does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

LCT - Living Cell Technologies
What is xenotransplantation?
The use of living animal cells, tissues or organs in human therapeutics. >more

What is DiabeCell?
DiabeCell is a porcine pancreatic cell product for the treatment of insulin-dependent diabetes. >more

What is NeurotrophinCell?
A choroid plexus (brain) cell product with the potential to treat diseases of the nervous system such as Huntington's disease and stroke. >more

What is LCT's encapsulation technology?
The living cells are covered in a seaweed-derived coating (alginate encapsulation) to form capsules which eliminate the
need for toxic immunosuppressant drugs and allow the release of beneficial factors.
>more
   
graphic design and website design - PDF Communications Ltd